Atlas Trials

KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD

Clinical trial NCT03460652 · COMPLETED

Trial details

NCT number
NCT03460652
Sponsor
Zevra Therapeutics
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
ADHD
Start date
2018-03-13
Primary completion
2019-06-20
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.